The NS2 protein of hepatitis C virus is a transmembrane polypeptide.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 189684)

Published in J Virol on December 01, 1995

Authors

E Santolini1, L Pacini, C Fipaldini, G Migliaccio, N Monica

Author Affiliations

1: Istituto di Ricerche di Biologia Molecolare, Angeletti, Pomezia, Italy.

Articles citing this

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol (2002) 6.69

Protein-protein interactions between hepatitis C virus nonstructural proteins. J Virol (2003) 2.23

Characterization of an autonomous subgenomic pestivirus RNA replicon. J Virol (1998) 2.16

Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol (2009) 1.76

Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol (1999) 1.75

Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem (2008) 1.71

Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol (2010) 1.66

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol (2008) 1.60

Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog (2009) 1.52

A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication. PLoS Pathog (2015) 1.46

Cytopathogenicity of a pestivirus correlates with a 27-nucleotide insertion. J Virol (1996) 1.44

Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J Virol (2004) 1.39

Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol (1996) 1.39

Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol (2003) 1.35

A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus. J Virol (2001) 1.35

Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol (2005) 1.32

Hepatitis C virus proteins. World J Gastroenterol (2007) 1.28

Host cell factor requirement for hepatitis C virus enzyme maturation. Proc Natl Acad Sci U S A (2001) 1.27

Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon. J Virol (2004) 1.26

Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein. J Virol (2001) 1.24

Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus. J Virol (2009) 1.21

A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV). PLoS One (2012) 1.20

In vitro study of the NS2-3 protease of hepatitis C virus. J Virol (1997) 1.18

Folding of hepatitis C virus E1 glycoprotein in a cell-free system. J Virol (2001) 1.02

The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein. J Gen Virol (2010) 0.99

Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol (1997) 0.94

Correlation between point mutations in NS2 and the viability and cytopathogenicity of Bovine viral diarrhea virus strain Oregon analyzed with an infectious cDNA clone. J Virol (2000) 0.92

Exploitation of lipid components by viral and host proteins for hepatitis C virus infection. Front Microbiol (2012) 0.92

Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein. J Virol (2013) 0.90

Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. J Virol (2012) 0.87

The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses (2010) 0.86

Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm. PLoS One (2013) 0.85

Complete translation of the hepatitis C virus genome in vitro: membranes play a critical role in the maturation of all virus proteins except for NS3. J Virol (2005) 0.82

Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs. Genet Vaccines Ther (2011) 0.77

Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma. Mol Med Rep (2015) 0.76

Viroporins, Examples of the Two-Stage Membrane Protein Folding Model. Viruses (2015) 0.75

Articles cited by this

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58

A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res (1988) 26.70

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res (1984) 14.92

Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92

Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47

Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33

Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A (1991) 7.15

Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01

A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res (1989) 6.78

Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36

Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci U S A (1989) 5.23

NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol (1993) 4.60

Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol (1993) 4.57

A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A (1993) 3.68

Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol (1994) 3.61

Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol (1994) 3.51

Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol (1994) 3.35

Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18

Transport of proteins across the endoplasmic reticulum membrane. Science (1992) 3.07

The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun (1993) 2.67

Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol (1994) 2.64

At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A (1992) 2.56

Formation of a functional ribosome-membrane junction during translocation requires the participation of a GTP-binding protein. J Cell Biol (1986) 2.44

Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol (1994) 2.38

Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28

Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology (1994) 2.27

Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proc Natl Acad Sci U S A (1994) 1.57

Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol (1994) 1.45

Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology (1994) 1.45

Nascent secretory chain binding and translocation are distinct processes: differentiation by chemical alkylation. J Cell Biol (1989) 1.25

Biochemical fractionation and assembly of the membrane components that mediate nascent chain targeting and translocation. Cell (1991) 1.18

Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector. Arch Virol (1993) 1.12

Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro. J Gen Virol (1994) 1.02

Articles by these authors

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15

Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19

Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. Nature (1985) 1.87

Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68

Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51

Palmitylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J Biol Chem (1989) 1.45

Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition. J Clin Invest (1986) 1.39

Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38

Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35

Role of signal recognition particle in the membrane assembly of Sindbis viral glycoproteins. Eur J Biochem (1984) 1.34

Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res (1990) 1.30

Free diffusion to and from the inner nuclear membrane of newly synthesized plasma membrane glycoproteins. J Cell Biol (1987) 1.27

Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci U S A (1984) 1.24

Biochemical fractionation and assembly of the membrane components that mediate nascent chain targeting and translocation. Cell (1991) 1.18

In vitro study of the NS2-3 protease of hepatitis C virus. J Virol (1997) 1.18

Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood (2000) 1.14

Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A (1991) 1.12

Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology (1998) 1.06

Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol (1994) 1.04

In vivo expansion of purified hematopoietic stem cells transplanted in nonablated W/Wv mice. Exp Hematol (1999) 1.03

Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues. J Cell Biol (1992) 1.00

Development of humanized mice for the study of hepatitis C virus infection. Transplant Proc (2006) 1.00

Biosynthesis and oligosaccharide structure of human CD8 glycoprotein expressed in a rat epithelial cell line. J Biol Chem (1992) 0.99

A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation. Int J Androl (2012) 0.98

Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches. Proc Natl Acad Sci U S A (1980) 0.97

Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells. Gene (2000) 0.96

Basal turn cochleostomy via the middle fossa route for cochlear implant insertion. Am J Otol (1998) 0.95

Identification and characterization of three classes of erythroid progenitors in human fetal liver. Blood (1981) 0.94

Chimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virus. J Virol (1997) 0.93

A new determinant of endoplasmic reticulum localization is contained in the juxtamembrane region of the ectodomain of hepatitis C virus glycoprotein E1. J Biol Chem (2000) 0.92

Reconstitution of secretory protein translocation from detergent-solubilized rough microsomes. Methods Cell Biol (1991) 0.91

In vitro interactions of PGE and cAMP with murine and human erythroid precursors. Blood (1980) 0.91

Biosynthesis of Hb in individual fetal liver bursts. gamma-Chain production peaks earlier than beta-chain in the erythropoietic pathway. Exp Cell Res (1980) 0.91

Stem cell factor induces proliferation and differentiation of fetal progenitor cells in the mouse. Br J Haematol (1998) 0.89

Regional distribution of Sindbis virus glycoproteins on the plasma membrane of infected baby hamster kidney cells. Exp Cell Res (1987) 0.88

Kinetics of erythroid precursors in mice infected with the anemic or the polycythemic strain of Friend leukemia virus. Proc Natl Acad Sci U S A (1980) 0.87

Influence of recombinant hematopoietins and of fetal bovine serum on the globin synthetic pattern of human BFUe. Blood (1990) 0.87

Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chains. Blood (1980) 0.86

Human embryonic hemopoiesis: control mechanisms underlying progenitor differentiation in vitro. Dev Biol (1988) 0.85

Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase. Xenobiotica (2006) 0.84

Lineage-restricted expression of protein kinase C isoforms in hematopoiesis. Blood (1999) 0.84

In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries. J Virol (2000) 0.83

Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood (1994) 0.83

Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32D. Blood (1993) 0.83

Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses. J Virol (1999) 0.82

Induced crossing-over in Drosophila melanogaster germ cells of DNA repair-proficient and repair-deficient (mei-9L1) males following larval feeding with 5-azacytidine and mitomycin C. Mutat Res (1992) 0.82

Establishing an employee baseline purified protein derivative status in the division of immigration health Service Processing Centers. J Community Health (2001) 0.82

Muscle carnitine palmityltransferase deficiency: a case with enzyme deficiency in cultured fibroblasts. Ann Neurol (1978) 0.81

A study of the mechanism by which some amphiphilic drugs affect human erythrocyte acetylcholinesterase activity. Biochem J (1989) 0.81

Molecular control of erythroid differentiation. Int J Hematol (1996) 0.81

Hemopoietic development in human embryos. Blood Cells (1984) 0.80

Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 protein. J Immunol (1996) 0.80

Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines. Blood (1993) 0.80

Early fluctuations of BFU-E pool size after transfusion or erythropoietin treatment. Exp Hematol (1979) 0.80

Circulating hematopoietic progenitor cells in a fetus with alpha thalassemia: comparison with the cells circulating in normal and non-thalassemic anemia fetuses and implications for in utero transplantations. Bone Marrow Transplant (2002) 0.79

A study of human erythrocyte acetylcholinesterase inhibition by chlorpromazine. Biochem J (1991) 0.79

The biology of stem cell factor, a new hematopoietic growth factor involved in stem cell regulation. Int J Clin Lab Res (1993) 0.79

Fluctuations of BFUe and CFUe cycling after erytrhoid perturbations: correlation with variations of pool size. Exp Hematol (1980) 0.79

Long-term generation of colony-forming cells (CFC) from CD34+ human umbilical cord blood cells. Leuk Lymphoma (1993) 0.79

Arachidonic acid incorporation and redistribution in human neuroblastoma (SK-N-BE) cell phospholipids. J Neurochem (1990) 0.78

Direct effects of IL-4 on the in vitro differentiation and proliferation of hematopoietic progenitor cells. Biotechnol Ther (1993) 0.78

A model for hemoglobin F synthesis in adult life: evidence for regulation at the level of erythroblasts. Ann N Y Acad Sci (1985) 0.78

Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. J Cell Physiol (1997) 0.78

Bromodeoxyuridine treatment of normal adult erythroid colonies: an in vitro model for reactivation of human fetal globin genes. Blood (1986) 0.78

Hereditary motor and sensory neuropathy type I and type II. Ital J Neurol Sci (1990) 0.78

Expression of phosphoinositide-specific phospholipase C isoforms in human umbilical vein endothelial cells. J Clin Pathol (2011) 0.78

The generation of colony-forming cells (CFC) and the expansion of hematopoiesis in cultures of human cord blood cells is dependent on the presence of stem cell factor (SCF). Cytotechnology (1993) 0.78

Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and leukemia inhibitory factor (LIF) protect the repopulating ability of purified murine hematopoietic stem cells in serum-deprived cultures stimulated with SCF and IL-3. Ann Ist Super Sanita (1999) 0.78

Biosynthesis of globin chains in fetal liver and adult marrow cultures. Exp Cell Res (1981) 0.77

The control of proliferation and differentiation of early erythroid progenitors. Biotherapy (1990) 0.77

Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2. Bone Marrow Transplant (2003) 0.77

Assessment of circulatory adjustments during underwater apnoea in elite divers by means of a portable device. Acta Physiol (Oxf) (2012) 0.77

Purification and characterization of an antifungal thaumatin-like protein from Cassia didymobotrya cell culture. Plant Physiol Biochem (2006) 0.77

Functional characterization of lymphoid cells generated in serum-deprived culture stimulated with stem cell factor and interleukin 7 from normal and autoimmune mice. J Cell Physiol (1995) 0.77

Expression in hematopoietic cells of GATA-1 transcripts from the alternative "testis" promoter during development and cell differentiation. Biochem Biophys Res Commun (1997) 0.77

Effect of recombinant hematopoietic growth factors on proliferation of human marrow progenitor cells in serum-deprived liquid culture. Blood (1988) 0.77

Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene (1994) 0.77

Erythropoietic differentiation in humans: in vitro studies on erythroid progenitors and Hb synthesis in fetal, newborn and adult life. Exp Hematol (1980) 0.76

mRNA activity of a Sindbis virus defective-interfering RNA. J Virol (1985) 0.76

Standardization of progenitor cell assay for cord blood banking. Ann Ist Super Sanita (2001) 0.76

Erythroid stem cell kinetics: experimental and clinical aspects. Blood Cells (1978) 0.76

Phosphoinositide-derived diacylglycerol conversion to phosphatidic acid is a receptor-dependent and compartmentalized phenomenon in human neuroblastoma. Neurosci Lett (1996) 0.76

Expression of the interleukin-3 and granulocyte-macrophage colony-stimulating factor genes in Friend spleen focus-forming virus-induced erythroleukemia. Blood (1992) 0.76

Rubidium shows effects different from lithium on phosphatidylinositol metabolism in a cell line of human neuroblastoma. Funct Neurol (1992) 0.75

Umbilical cord blood cells: informed consent. Bone Marrow Transplant (1995) 0.75

Evidence for direct action of human biosynthetic (recombinant) GM-CSF on erythroid progenitors in serum-free culture. Blood (1987) 0.75

Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony-stimulating factor in vivo. Blood (1990) 0.75

Testosterone action on BFU-E and CFU-E: correlation between enhancement of proliferative rate and amplification of pool size. Life Sci (1979) 0.75

Cellular and molecular mechanisms of the human embryonic leads to fetal hemoglobin switch. Prog Clin Biol Res (1983) 0.75

In vitro regulation of Hb synthesis: studies in normal subjects and thalassemic patients. Birth Defects Orig Artic Ser (1982) 0.75

Mechanisms regulating the kinetics of erythroid burst- (BFU-E) and colony-forming unit (CFU-E). Haematologica (1978) 0.75

Role of kidney, liver and hypophysis in erythropoietin production. Haematologica (1978) 0.75

Erythropoietic development and hemoglobin switching in human embryos: cellular and molecular aspects. Prog Clin Biol Res (1985) 0.75

[Radicular anomalies]. Riv Neurobiol (1985) 0.75

[Determination of sialic acid and the amount of hexosamine in the cerebrospinal fluid in various neurologic diseases]. Riv Neurobiol (1966) 0.75

The early stage of Friend virus erythroleukemias: mechanisms underlying BPA-"independent" in vitro growth of BFU-E. Haematol Blood Transfus (1983) 0.75